Renalytix Plc (RENX.L)
GBp 7.5
(-6.25%)
GBp 7.5
(-6.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.2 Billion EUR | 35209.83% |
| 2022 | 43.05 Million USD | -26.13% |
| 2021 | 58.29 Million USD | 75.06% |
| 2020 | 33.29 Million USD | 276.28% |
| 2019 | 8.84 Million USD | 35.37% |
| 2018 | 6.53 Million USD | -99.96% |
| 2017 | 17.49 Billion EUR | 13.38% |
| 2016 | 15.43 Billion EUR | -4.81% |
| 2015 | 16.21 Billion EUR | 10.88% |
| 2014 | 14.62 Billion EUR | -19.8% |
| 2013 | 18.23 Billion EUR | -0.33% |
| 2012 | 18.29 Billion EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 9.24 Million USD | 4.49% |
| 2023 FY | 15.2 Billion EUR | 35209.83% |
| 2023 Q1 | 8.84 Million USD | -9.54% |
| 2022 FY | 43.05 Million USD | -26.13% |
| 2022 Q3 | 11.03 Million USD | 8.97% |
| 2022 Q2 | 10.12 Million USD | -15.56% |
| 2022 Q1 | 11.99 Million USD | -9.55% |
| 2022 Q4 | 9.77 Million USD | -11.41% |
| 2021 Q2 | 14.13 Million USD | 17.12% |
| 2021 Q3 | 14.66 Million USD | 3.74% |
| 2021 Q4 | 13.26 Million USD | -9.57% |
| 2021 FY | 58.29 Million USD | 75.06% |
| 2021 Q1 | 12.06 Million USD | 13.67% |
| 2020 Q2 | 8.75 Million USD | 62.06% |
| 2020 FY | 33.29 Million USD | 276.28% |
| 2020 Q3 | 8.65 Million USD | -1.2% |
| 2020 Q1 | 5.4 Million USD | 48.07% |
| 2020 Q4 | 10.61 Million USD | 22.74% |
| 2019 Q1 | 2.01 Million USD | -99.98% |
| 2019 FY | 8.84 Million USD | 35.37% |
| 2019 Q4 | 3.64 Million USD | 36.11% |
| 2019 Q2 | 2.73 Million USD | 35.4% |
| 2019 Q3 | 2.68 Million USD | -1.83% |
| 2018 Q4 | 12.19 Billion EUR | 1.38% |
| 2018 Q3 | 12.02 Billion EUR | 69.47% |
| 2018 Q2 | 7.09 Billion EUR | -1.68% |
| 2018 Q1 | 7.21 Billion EUR | 9115053.13% |
| 2018 FY | 6.53 Million USD | -99.96% |
| 2017 Q3 | 13.39 Billion EUR | 170.22% |
| 2017 FY | 17.49 Billion EUR | 13.38% |
| 2017 Q4 | 79.17 Thousand USD | -100.0% |
| 2017 Q2 | 4.95 Billion EUR | 1.46% |
| 2017 Q1 | 4.88 Billion EUR | -62.55% |
| 2016 FY | 15.43 Billion EUR | -4.81% |
| 2016 Q4 | 13.05 Billion EUR | 7.06% |
| 2016 Q2 | 4.1 Billion EUR | -6.3% |
| 2016 Q1 | 4.38 Billion EUR | -64.86% |
| 2016 Q3 | 12.19 Billion EUR | 196.71% |
| 2015 Q4 | 12.47 Billion EUR | -2.49% |
| 2015 FY | 16.21 Billion EUR | 10.88% |
| 2015 Q3 | 12.79 Billion EUR | 184.8% |
| 2015 Q2 | 4.49 Billion EUR | -2.68% |
| 2015 Q1 | 4.61 Billion EUR | -64.27% |
| 2014 Q4 | 12.92 Billion EUR | 3.69% |
| 2014 Q3 | 12.46 Billion EUR | 170.0% |
| 2014 FY | 14.62 Billion EUR | -19.8% |
| 2014 Q1 | 4.81 Billion EUR | -64.32% |
| 2014 Q2 | 4.61 Billion EUR | -4.09% |
| 2013 Q4 | 13.48 Billion EUR | -0.64% |
| 2013 Q1 | 5.67 Billion EUR | -59.61% |
| 2013 Q3 | 13.57 Billion EUR | 135.02% |
| 2013 Q2 | 5.77 Billion EUR | 1.75% |
| 2013 FY | 18.23 Billion EUR | -0.33% |
| 2012 Q3 | 13.85 Billion EUR | 164.24% |
| 2012 Q4 | 14.05 Billion EUR | 1.46% |
| 2012 FY | 18.29 Billion EUR | 0.0% |
| 2012 Q1 | 5.32 Billion EUR | 0.0% |
| 2012 Q2 | 5.24 Billion EUR | -1.62% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|